InMed Prognostics provides an AI and machine learning-based MRI tool designed for neuro radiologists, neuro physicians, and psychiatrists. This technology enhances diagnostic accuracy by analyzing brain imaging data to identify neurological conditions more effectively.
Funding
Funding not disclosed
Founders
Product
Problem
Neurological conditions are often diagnosed through MRI analysis, a process that can be time-consuming and prone to human error. The subtle indicators of diseases may be missed, leading to delayed or inaccurate diagnoses. This can result in delayed treatment and poorer patient outcomes.
Solution
InMed Prognostics offers an AI-powered MRI analysis tool designed to improve the accuracy and efficiency of neurological diagnoses. The technology applies machine learning algorithms to brain imaging data, assisting radiologists, neurologists, and psychiatrists in identifying subtle indicators of neurological conditions. By automating aspects of image analysis and providing quantitative data, the tool aims to reduce diagnostic errors and accelerate the time to diagnosis. This enables clinicians to make more informed decisions and initiate timely interventions for patients.
Target Audience
The primary target audience includes neuroradiologists, neurologists, psychiatrists, and hospitals utilizing MRI for neurological diagnosis.
Features
- AI-driven analysis of MRI scans for enhanced detection of neurological conditions
- Machine learning algorithms trained on extensive datasets of brain images
- Quantitative data and visualizations to support diagnostic decision-making
- Integration with existing MRI workflows for seamless implementation
- Automated reporting features to streamline documentation